iShares US Pharmaceuticals ETF
IHE
IHE
95 hedge funds and large institutions have $348M invested in iShares US Pharmaceuticals ETF in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 24 increasing their positions, 37 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
35% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 37
Holders
95
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$13.7M | |
| 2 | +$5.41M | |
| 3 | +$1.51M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$871K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$622K |
Top Sellers
| 1 | -$5.84M | |
| 2 | -$5.78M | |
| 3 | -$5.5M | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$5.06M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.38M |